| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0099 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |